103 related articles for article (PubMed ID: 6582584)
1. Interferon-alpha treatment of a patient with acute lymphoblastic leukaemia and Down's syndrome. Effects on natural killer cell activity and mitogen responsiveness.
Bratt G; Einhorn S; Blomgren H; Gahrton G; Paul C; Strander H
Scand J Haematol; 1984 Jan; 32(1):49-54. PubMed ID: 6582584
[TBL] [Abstract][Full Text] [Related]
2. Natural killer cell activity in childhood acute lymphoblastic leukaemia in remission.
Dickinson AM; Proctor SJ; Jacobs E; Reid MM; Walker W; Craft AW; Kernahan J
Br J Haematol; 1985 Jan; 59(1):45-53. PubMed ID: 3855649
[TBL] [Abstract][Full Text] [Related]
3. Immunomodulation of natural killer activity in children with acute lymphoblastic leukaemia.
Jermy A; Jennings R; Lilleyman JS; Rees RC
Eur J Cancer Clin Oncol; 1987 Sep; 23(9):1371-7. PubMed ID: 3500050
[TBL] [Abstract][Full Text] [Related]
4. Altered natural killer cell activity in childhood acute non-lymphoid leukaemia. Augmented natural killer cell activity and cells expressing the Leu 7 and Leu 11b (CD 16) markers in the bone marrow of children in remission.
Sørskaar D; Førre O; Tjønneland S; Lie SO
Scand J Immunol; 1988 Jul; 28(1):11-7. PubMed ID: 3261034
[TBL] [Abstract][Full Text] [Related]
5. Influence of human interferon-alpha therapy on cytotoxic functions of blood lymphocytes. Studies on lectin-dependent cellular cytotoxicity, antibody-dependent cellular cytotoxicity, and natural killer cell activity.
Einhorn S; Blomgren H; Strander H; Wasserman J
Cancer Immunol Immunother; 1983; 16(2):77-80. PubMed ID: 6559104
[TBL] [Abstract][Full Text] [Related]
6. Increased natural killer cell activity and numbers of Leu-7 and Leu-11b (CD 16)-positive cells in bone marrow of children in remission from acute lymphoblastic leukaemia.
Sørskaar D; Førre O; Lie SO
Scand J Immunol; 1989 Jan; 29(1):65-72. PubMed ID: 2466327
[TBL] [Abstract][Full Text] [Related]
7. Alpha-interferon activates the natural killer system in patients with hairy cell leukemia.
Semenzato G; Pizzolo G; Agostini C; Ambrosetti A; Zambello R; Trentin L; Luca M; Masciarelli M; Chilosi M; Vinante F
Blood; 1986 Jul; 68(1):293-6. PubMed ID: 3719101
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the natural killer cell-interferon system in patients with mid-gut carcinoid tumours treated with leucocyte interferon.
Funa K; Alm GV; Rönnblom L; Oberg K
Clin Exp Immunol; 1983 Sep; 53(3):716-24. PubMed ID: 6616963
[TBL] [Abstract][Full Text] [Related]
9. Vincristine and prednisone for the induction of remissions in acute childhood leukaemia.
Hardisty RM; McElwain TJ; Darby CW
Br Med J; 1969 Jun; 2(5658):662-5. PubMed ID: 5254045
[TBL] [Abstract][Full Text] [Related]
10. Lymphocyte functions of child patients with ALL (acute lymphoblastic leukemia) in remission.
Suzuki M
Jpn J Clin Oncol; 1984 Mar; 14(1):31-40. PubMed ID: 6231391
[TBL] [Abstract][Full Text] [Related]
11. Analysis of natural killer cell cytotoxicity of cancer patients treated with recombinant interferon.
Lotzová E; Savary CA; Quesada JR; Gutterman JU; Hersh EM
J Natl Cancer Inst; 1983 Nov; 71(5):903-10. PubMed ID: 6580490
[TBL] [Abstract][Full Text] [Related]
12. Intensive chemotherapy induction followed by interferon-alpha maintenance in patients with Philadelphia chromosome-positive chronic myelogenous leukemia.
Kantarjian HM; Talpaz M; Keating MJ; Estey EH; O'Brien S; Beran M; McCredie KB; Gutterman J; Freireich EJ
Cancer; 1991 Sep; 68(6):1201-7. PubMed ID: 1873771
[TBL] [Abstract][Full Text] [Related]
13. Studies on the optimal dose and the mode of action of alpha-interferon in the treatment of hairy cell leukemia.
Huber C; Aulitzky W; Tilg H; von Lüttichau I; Troppmair J; Nachbauer K; Gastl G
Leukemia; 1987 Apr; 1(4):355-7. PubMed ID: 3669762
[TBL] [Abstract][Full Text] [Related]
14. In vitro modulation of human natural killer cell activity by interferon: generation of adherent suppressor cells.
Uchida A; Yanagawa E; Kokoschka EM; Micksche M; Koren HS
Br J Cancer; 1984 Oct; 50(4):483-92. PubMed ID: 6237664
[TBL] [Abstract][Full Text] [Related]
15. Analysis of natural killer cell defects in childhood acute lymphoblastic leukemia.
Yamada S; Miyagawa Y; Komiyama A; Akabane T
Jpn J Clin Oncol; 1984 Mar; 14(1):75-80. PubMed ID: 6608609
[TBL] [Abstract][Full Text] [Related]
16. Correlation between in vitro and systemic effects of native and recombinant interferons-alpha on human natural killer cell cytotoxicity.
Edwards BS; Hawkins MJ; Borden EC
J Biol Response Mod; 1983; 2(5):409-17. PubMed ID: 6644345
[TBL] [Abstract][Full Text] [Related]
17. Lysis of fresh leukemic blasts by interferon-activated human natural killer cells.
Pattengale PK; Sundstrom C; Yu AL; Levine A
Nat Immun Cell Growth Regul; 1983-1984; 3(4):165-80. PubMed ID: 6597341
[TBL] [Abstract][Full Text] [Related]
18. The in vitro detection of anti-leukaemia-specific cytotoxicity after autologous bone marrow transplantation for acute leukaemia.
Lowdell MW; Ray N; Craston R; Corbett T; Deane M; Prentice HG
Bone Marrow Transplant; 1997 May; 19(9):891-7. PubMed ID: 9156262
[TBL] [Abstract][Full Text] [Related]
19. The influence of sequential chemotherapy and radiotherapy on mitogen-induced lymphocyte transformation in patients with acute lymphoblastic leukemia.
Humphrey GB; Parker DE
Med Pediatr Oncol; 1976; 2(1):29-37. PubMed ID: 934028
[TBL] [Abstract][Full Text] [Related]
20. Alpha-interferon induces remission in hairy cell leukemia without enhancement of natural killing.
Gastl G; Aulitzky W; Leiter E; Flener R; Huber C
Blut; 1986 May; 52(5):273-9. PubMed ID: 3635416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
